To include your compound in the COVID-19 Resource Center, submit it here.

DNDi, partners aim to bring cheaper HCV combo to Latin America

The Drugs for Neglected Diseases initiative said it will partner with three pharmaceutical companies and a non-profit to sell a cheaper HCV regimen in Latin America. HCV patients pay at least $7,000 in Argentina, $12,000 in

Read the full 369 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers